February 28, 2022
Video
On Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
February 16, 2022
Video
The director of the Division of Neuromuscular Diseases at UC Irvine discussed the positive data, noting that the treatment was “incredibly safe.” [WATCH TIME: 4 minutes]
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD
Periconceptional Folic Acid Supplementation Decreases Risk of Preterm Birth in Epilepsy
Changing the Future of Stroke Care: The 2021 ASA/AHA Prevention Guidelines